What does DUOMEDIC do?

DUOMEDIC is a general practice in Evere. Private Limited, started on 8 May 1998.

What is the address of DUOMEDIC?

The registered office of DUOMEDIC is located at Edward Dekosterstraat 64 box 80, 1140 Evere.

Is DUOMEDIC still active?

Yes. According to the CBE (31 October 2026) DUOMEDIC is active, legal situation “Normale toestand”, started on 8 May 1998.

Is DUOMEDIC registered on Peppol?

Yes, DUOMEDIC is registered on the Peppol network with ID 0208:0463333564.

What is the enterprise number of DUOMEDIC?

The enterprise number of DUOMEDIC is BE0463333564.

When was DUOMEDIC founded?

DUOMEDIC was founded on 8 May 1998.

Who are the directors of DUOMEDIC?

According to the 2025 annual accounts, the directors of DUOMEDIC are: HELENE LONCIN, GUY METZ.

Is DUOMEDIC a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 May 1998; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DUOMEDIC make in 2025?

DUOMEDIC posted a profit after taxes of € 33,754 in financial year 2025.

What is the revenue of DUOMEDIC?

In its most recent annual accounts (2025), DUOMEDIC reported revenue of € 87,296.

DUOMEDIC (Private Limited) - Evere - BE0463333564

Dossier DUOMEDIC, printed on 31 October 2026 from databakkes.be/en/0463333564/duomedic. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DUOMEDIC from Evere, company number BE0463333564, closed financial year 2025 with a result of € 33,754 after tax. For that financial year DUOMEDIC recorded revenue of € 87,296 and equity of € 445,583. Compared with financial year 2024, the result moved from € 32,557 to € 33,754. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.

What it is worth Healthy

€ 445,583

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 33,754

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 423,409

▼ 10% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 45,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 51,223

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,009

▼ 46% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,774

▼ 75% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 95,918 Revenue 2022: € 95,918 First fiscal year in the series	€ 105,341 Revenue 2023: € 105,341 ▲ 10% vs 2022 (€ 95,918) Favourable step	€ 96,539 Revenue 2024: € 96,539 ▼ 8% vs 2023 (€ 105,341) Unfavourable step	€ 87,296 Revenue 2025: € 87,296 ▼ 10% vs 2024 (€ 96,539) Unfavourable step	▼ 10%
Gross margin	€ 25,130 Gross margin 2022: € 25,130 First fiscal year in the series	€ 58,514 Gross margin 2023: € 58,514 ▲ 133% vs 2022 (€ 25,130) Favourable step	€ 51,830 Gross margin 2024: € 51,830 ▼ 11% vs 2023 (€ 58,514) Unfavourable step	€ 56,282 Gross margin 2025: € 56,282 ▲ 9% vs 2024 (€ 51,830) Favourable step	▲ 9%
Profit after taxes	€ 13,260 Profit after taxes 2022: € 13,260 First fiscal year in the series	€ 43,255 Profit after taxes 2023: € 43,255 ▲ 226% vs 2022 (€ 13,260) Favourable step	€ 32,557 Profit after taxes 2024: € 32,557 ▼ 25% vs 2023 (€ 43,255) Unfavourable step	€ 33,754 Profit after taxes 2025: € 33,754 ▲ 4% vs 2024 (€ 32,557) Favourable step	▲ 4%
Equity	€ 481,357 Equity 2022: € 481,357 First fiscal year in the series	€ 424,272 Equity 2023: € 424,272 ▼ 12% vs 2022 (€ 481,357) Unfavourable step	€ 456,828 Equity 2024: € 456,828 ▲ 8% vs 2023 (€ 424,272) Favourable step	€ 445,583 Equity 2025: € 445,583 ▼ 2% vs 2024 (€ 456,828) Unfavourable step	▼ 2%
Total debts	€ 2,199 Total debts 2022: € 2,199 First fiscal year in the series	€ 116,510 Total debts 2023: € 116,510 ▲ € 114,311 vs 2022 (€ 2,199) Unfavourable step	€ 21,852 Total debts 2024: € 21,852 ▼ 81% vs 2023 (€ 116,510) Favourable step	€ 34,889 Total debts 2025: € 34,889 ▲ 60% vs 2024 (€ 21,852) Unfavourable step	▲ 60%
Cash	€ 481,488 Cash 2022: € 481,488 First fiscal year in the series	€ 483,567 Cash 2023: € 483,567 Unchanged (€ 481,488) Favourable step	€ 471,856 Cash 2024: € 471,856 ▼ 2% vs 2023 (€ 483,567) Unfavourable step	€ 423,409 Cash 2025: € 423,409 ▼ 10% vs 2024 (€ 471,856) Unfavourable step	▼ 10%
Retained profit	€ 475,152 Retained profit 2022: € 475,152 First fiscal year in the series	€ 418,066 Retained profit 2023: € 418,066 ▼ 12% vs 2022 (€ 475,152) Unfavourable step	€ 450,623 Retained profit 2024: € 450,623 ▲ 8% vs 2023 (€ 418,066) Favourable step	€ 439,377 Retained profit 2025: € 439,377 ▼ 2% vs 2024 (€ 450,623) Unfavourable step	▼ 2%
Dividend	€ 59,892 Dividend 2022: € 59,892 First fiscal year in the series	€ 100,341 Dividend 2023: € 100,341 ▲ 68% vs 2022 (€ 59,892) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 100,341) Unchanged	€ 45,000 Dividend 2025: € 45,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 483,556 Balance sheet total 2022: € 483,556 First fiscal year in the series	€ 540,781 Balance sheet total 2023: € 540,781 ▲ 12% vs 2022 (€ 483,556) Unchanged	€ 478,681 Balance sheet total 2024: € 478,681 ▼ 11% vs 2023 (€ 540,781) Unchanged	€ 480,472 Balance sheet total 2025: € 480,472 Unchanged (€ 478,681) Unchanged

Key figures of DUOMEDIC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DUOMEDIC?

What happened at DUOMEDIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 6, 2026 New annual accounts for financial year 2025: profit of € 33,754 (▲ 4% vs 2024). Source: NBB ↗
May 8, 1998 Start of the company according to the CBE. KBO

In short

From € 13,260 profit in 2022 to € 33,754 profit in 2025.

Paid € 54,171 in corporate taxes since 2022.

Best year ever: 2023, with € 43,255 profit.

Paid out € 205,233 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

HELENE LONCIN GUY METZ

DUOMEDIC

Behind DUOMEDIC are HELENE LONCIN and GUY METZ.

Directors

According to the 2025 annual accounts

HELENE LONCIN

Administrator-manager

GUY METZ

Administrator-manager

Establishments

Establishment units

Physical locations of this company

Registered office

Edward Dekosterstraat 64 box 80

1140 Evere

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.

All companies at this address →

ADetec Bénélux

€ 254,606 revenue · 2025

CABRIOLE ASBL

ASSOCIATION DES VICTIMES DE L'ATTENTAT DU 6 AVRIL 1994

PracticeVantage Europe

€ 27,424 gross margin · 2025

A.C.P. RUE E.DEKOSTER 64 EVERE

+2 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0463.333.564
VAT number: BE 0463.333.564
Registered office: Edward Dekosterstraat 64 bus 80, 1140 Evere
Names & denominations: DUOMEDIC
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 May 1998
Peppol: Active · Active since 6 Feb 2026
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗